The Aurora Kinase Inhibitor CYC116 Promotes the Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells |
Sijia, Ji
(School of Life Science and Technology, ShanghaiTech University)
Wanzhi, Tu (School of Life Science and Technology, ShanghaiTech University) Chenwen, Huang (State Key Laboratory of Drug Research, The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences) Ziyang, Chen (State Key Laboratory of Drug Research, The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences) Xinyue, Ren (State Key Laboratory of Drug Research, The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences) Bingqing, He (School of Life Science and Technology, ShanghaiTech University) Xiaoyan, Ding (Stem Cell Bank/Stem Cell Core Facility, Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences) Yuelei, Chen (Stem Cell Bank/Stem Cell Core Facility, Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences) Xin, Xie (School of Life Science and Technology, ShanghaiTech University) |
1 | Angst, B.D., Khan, L.U., Severs, N.J., Whitely, K., Rothery, S., Thompson, R.P., Magee, A.I., and Gourdie, R.G. (1997). Dissociated spatial patterning of gap junctions and cell adhesion junctions during postnatal differentiation of ventricular myocardium. Circ. Res. 80, 88-94. DOI |
2 | Barth, E., Stammler, G., Speiser, B., and Schaper, J. (1992). Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man. J. Mol. Cell. Cardiol. 24, 669-681. DOI |
3 | Bergmann, O., Zdunek, S., Felker, A., Salehpour, M., Alkass, K., Bernard, S., Sjostrom, S.L., Szewczykowska, M., Jackowska, T., Dos Remedios, C., et al. (2015). Dynamics of cell generation and turnover in the human heart. Cell 161, 1566-1575. DOI |
4 | Bhattacharya, S., Burridge, P.W., Kropp, E.M., Chuppa, S.L., Kwok, W.M., Wu, J.C., Boheler, K.R., and Gundry, R.L. (2014). High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry. J. Vis. Exp. 91, 52010. |
5 | Borisa, A.C. and Bhatt, H.G. (2017). A comprehensive review on Aurora kinase: small molecule inhibitors and clinical trial studies. Eur. J. Med. Chem. 140, 1-19. DOI |
6 | Burridge, P.W., Matsa, E., Shukla, P., Lin, Z.C., Churko, J.M., Ebert, A.D., Lan, F., Diecke, S., Huber, B., Mordwinkin, N.M., et al. (2014). Chemically defined generation of human cardiomyocytes. Nat. Methods 11, 855-860. DOI |
7 | Cao, F., Wagner, R.A., Wilson, K.D., Xie, X., Fu, J.D., Drukker, M., Lee, A., Li, R.A., Gambhir, S.S., Weissman, I.L., et al. (2008). Transcriptional and functional profiling of Human pluripotent stem cell-derived cardiomyocytes. PLoS One 3, e3474. |
8 | Christoffels, V.M., Habets, P.E., Franco, D., Campione, M., de Jong, F., Lamers, W.H., Bao, Z.Z., Palmer, S., Biben, C., Harvey, R.P., et al. (2000). Chamber formation and morphogenesis in the developing mammalian heart. Dev. Biol. 223, 266-278. DOI |
9 | Du, J., Yan, L., Torres, R., Gong, X., Bian, H., Marugan, C., Boehnke, K., Baquero, C., Hui, Y.H., Chapman, S.C., et al. (2019). Aurora A-selective inhibitor LY3295668 leads to dominant mitotic arrest, apoptosis in cancer cells, and shows potent preclinical antitumor efficacy. Mol. Cancer Ther. 18, 2207-2219. DOI |
10 | Feric, N.T. and Radisic, M. (2016). Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. Adv. Drug Deliv. Rev. 96, 110-134. DOI |
11 | Garbern, J.C., Helman, A., Sereda, R., Sarikhani, M., Ahmed, A., Escalante, G.O., Ogurlu, R., Kim, S.L., Zimmerman, J.F., Cho, A., et al. (2020). Inhibition of mTOR signaling enhances maturation of cardiomyocytes derived from human-induced pluripotent stem cells via p53-induced quiescence. Circulation 141, 285-300. DOI |
12 | Goffart, S., von Kleist-Retzow, J.C., and Wiesner, R.J. (2004). Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy. Cardiovasc. Res. 64, 198-207. DOI |
13 | Gomez-Garcia, M.J., Quesnel, E., Al-Attar, R., Laskary, A.R., and Laflamme, M.A. (2021). Maturation of human pluripotent stem cell derived cardiomyocytes in vitro and in vivo. Semin. Cell Dev. Biol. 118, 163-171. DOI |
14 | Hu, D., Linders, A., Yamak, A., Correia, C., Kijlstra, J.D., Garakani, A., Xiao, L., Milan, D.J., van der Meer, P., Serra, M., et al. (2018). Metabolic maturation of human pluripotent stem cell-derived cardiomyocytes by inhibition of HIF1alpha and LDHA. Circ. Res. 123, 1066-1079. DOI |
15 | Kolanowski, T.J., Antos, C.L., and Guan, K. (2017). Making human cardiomyocytes up to date: derivation, maturation state and perspectives. Int. J. Cardiol. 241, 379-386. DOI |
16 | Jiang, Y., Park, P., Hong, S.M., and Ban, K. (2018). Maturation of cardiomyocytes derived from human pluripotent stem cells: current strategies and limitations. Mol. Cells 41, 613-621. DOI |
17 | Kadota, S., Pabon, L., Reinecke, H., and Murry, C.E. (2017). In vivo maturation of human induced pluripotent stem cell-derived cardiomyocytes in neonatal and adult rat hearts. Stem Cell Reports 8, 278-289. DOI |
18 | Kamakura, T., Makiyama, T., Sasaki, K., Yoshida, Y., Wuriyanghai, Y., Chen, J., Hattori, T., Ohno, S., Kita, T., Horie, M., et al. (2013). Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ. J. 77, 1307-1314. DOI |
19 | Liang, P., Lan, F., Lee, A.S., Gong, T., Sanchez-Freire, V., Wang, Y., Diecke, S., Sallam, K., Knowles, J.W., Wang, P.J., et al. (2013). Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation 127, 1677-1691. DOI |
20 | Liu, Y., Bai, H., Guo, F., Thai, P.N., Luo, X., Zhang, P., Yang, C., Feng, X., Zhu, D., Guo, J., et al. (2020). PPARGC1A activator ZLN005 promotes maturation of cardiomyocytes derived fromHuman pluripotent stem cells. Aging (Albany N.Y.) 12, 7411-7430. DOI |
21 | Lundy, S.D., Zhu, W.Z., Regnier, M., and Laflamme, M.A. (2013). Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev. 22, 1991-2002. DOI |
22 | Miao, S., Zhao, D., Wang, X., Ni, X., Fang, X., Yu, M., Ye, L., Yang, J., Wu, H., Han, X., et al. (2020). Retinoic acid promotes metabolic maturation of human embryonic stem cell-derived cardiomyocytes. Theranostics 10, 9686-9701. DOI |
23 | Noronha, S., Alt, L.A.C., Scimeca, T.E., Zarou, O., Obrzut, J., Zanotti, B., Hayward, E.A., Pillai, A., Mathur, S., Rojas, J., et al. (2018). Preclinical evaluation of the Aurora kinase inhibitors AMG 900, AZD1152-HQPA, and MK-5108 on SW-872 and 93T449 human liposarcoma cells. In Vitro Cell. Dev. Biol. Anim. 54, 71-84. DOI |
24 | Mills, R.J., Titmarsh, D.M., Koenig, X., Parker, B.L., Ryall, J.G., Quaife-Ryan, G.A., Voges, H.K., Hodson, M.P., Ferguson, C., Drowley, L., et al. (2017). Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest. Proc. Natl. Acad. Sci. U. S. A. 114, E8372-E8381. |
25 | Mollova, M., Bersell, K., Walsh, S., Savla, J., Das, L.T., Park, S.Y., Silberstein, L.E., Dos Remedios, C.G., Graham, D., Colan, S., et al. (2013). Cardiomyocyte proliferation contributes to heart growth in young humans. Proc. Natl. Acad. Sci. U. S. A. 110, 1446-1451. DOI |
26 | Moretti, A., Bellin, M., Welling, A., Jung, C.B., Lam, J.T., Bott-Flugel, L., Dorn, T., Goedel, A., Hohnke, C., Hofmann, F., et al. (2010). Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397-1409. DOI |
27 | Parikh, S.S., Blackwell, D.J., Gomez-Hurtado, N., Frisk, M., Wang, L., Kim, K., Dahl, C.P., Fiane, A., Tonnessen, T., Kryshtal, D.O., et al. (2017). Thyroid and glucocorticoid hormones promote functional T-tubule development in human-induced pluripotent stem cell-derived cardiomyocytes. Circ. Res. 121, 1323-1330. DOI |
28 | Ponnusamy, M., Li, P.F., and Wang, K. (2017). Understanding cardiomyocyte proliferation: an insight into cell cycle activity. Cell. Mol. Life Sci. 74, 1019-1034. DOI |
29 | Porrello, E.R., Mahmoud, A.I., Simpson, E., Hill, J.A., Richardson, J.A., Olson, E.N., and Sadek, H.A. (2011). Transient regenerative potential of the neonatal mouse heart. Science 331, 1078-1080. DOI |
30 | Robertson, C., Tran, D.D., and George, S.C. (2013). Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells 31, 829-837. DOI |
31 | Rog-Zielinska, E.A., Craig, M.A., Manning, J.R., Richardson, R.V., Gowans, G.J., Dunbar, D.R., Gharbi, K., Kenyon, C.J., Holmes, M.C., Hardie, D.G., et al. (2015). Glucocorticoids promote structural and functional maturation of foetal cardiomyocytes: a role for PGC-1alpha. Cell Death Differ. 22, 1106-1116. DOI |
32 | Ronaldson-Bouchard, K., Ma, S.P., Yeager, K., Chen, T., Song, L., Sirabella, D., Morikawa, K., Teles, D., Yazawa, M., and Vunjak-Novakovic, G. (2018). Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature 556, 239-243. DOI |
33 | Tang, A., Gao, K., Chu, L., Zhang, R., Yang, J., and Zheng, J. (2017). Aurora kinases: novel therapy targets in cancers. Oncotarget 8, 23937-23954. DOI |
34 | Tertoolen, L.G.J., Braam, S.R., van Meer, B.J., Passier, R., and Mummery, C.L. (2018). Interpretation of field potentials measured on a multi electrode array in pharmacological toxicity screening on primary and human pluripotent stem cell-derived cardiomyocytes. Biochem. Biophys. Res. Commun. 497, 1135-1141. DOI |
35 | Tseng, T.C., Chen, S.H., Hsu, Y.P., and Tang, T.K. (1998). Protein kinase profile of sperm and eggs: cloning and characterization of two novel testis-specific protein kinases (AIE1, AIE2) related to yeast and fly chromosome segregation regulators. DNA Cell Biol. 17, 823-833. DOI |
36 | Xu, X.Q., Soo, S.Y., Sun, W., and Zweigerdt, R. (2009). Global expression profile of highly enriched cardiomyocytes derived from Human pluripotent stem cells. Stem Cells 27, 2163-2174. DOI |
37 | Xue, Y., Cai, X., Wang, L., Liao, B., Zhang, H., Shan, Y., Chen, Q., Zhou, T., Li, X., Hou, J., et al. (2013). Generating a non-integrating human induced pluripotent stem cell bank from urine-derived cells. PLoS One 8, e70573. |
38 | Yang, X., Rodriguez, M.L., Leonard, A., Sun, L., Fischer, K.A., Wang, Y., Ritterhoff, J., Zhao, L., Kolwicz, S.C., Jr., Pabon, L., et al. (2019). Fatty acids enhance the maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cell Reports 13, 657-668. DOI |
39 | Yang, X., Pabon, L., and Murry, C.E. (2014). Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Res. 114, 511-523. DOI |
40 | Yang, X., Rodriguez, M., Pabon, L., Fischer, K.A., Reinecke, H., Regnier, M., Sniadecki, N.J., Ruohola-Baker, H., and Murry, C.E. (2014). Tri-iodo-lthyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. J. Mol. Cell. Cardiol. 72, 296-304. DOI |
41 | Yu, X., Liang, Q., Liu, W., Zhou, L., Li, W., and Liu, H. (2017). Deguelin, an Aurora B kinase inhibitor, exhibits potent anti-tumor effect in human esophageal squamous cell carcinoma. EBioMedicine 26, 100-111. DOI |